Vesugen
Tripeptide (Lys-Glu-Asp) from the Khavinson cytomedin lineage. Targeted at vascular endothelium — Russian Academy work claims normalization of vascular tone + endothelial repair in aging cohorts.
How it clearsHalf cleared in ~4h. Most (~96%) gone by ~20h.
Compare these compounds
Mechanism, evidence, legal path, cost — all side-by-side.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
One of dozens of Khavinson-lab synthetic-tetrapeptide / tripeptide bioregulators (Epitalon = pineal, Pinealon = brain, Cardiogen = heart, Vesugen = vessels, Bronchogen = lung, Pancrogen = pancreas, Testagen = immune). The whole family rests on Russian-academy clinical practice + cohort observations, with essentially zero Western RCT replication. Khavinson reported 6-year + 12-year follow-up data on combined cytomedin courses in Russian gerontology journals. Adoption outside Russia is biohacker-niche.
All efficacy evidence is Khavinson-lineage. Western replication is absent. Counterfeit + identity-verification problem for grey-market imports from Eastern Europe is severe. Don't conflate Vesugen with Pinealon, Cardiogen, etc — same lineage but different targets.
Upload your data to see how it relates to Vesugen.
Upload a lab file (LabCorp / Quest) or DNA file (23andMe / AncestryDNA). Stack will show your specific markers alongside the literature-reported response windows.
Upload in /historyPer-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
- DMechanistic / anecdotal
Vesugen — primary mechanism: tripeptide (lys-glu-asp) from the khavinson cytomedin lineage. targeted at vascular endothelium — russian academy work claims normalization of vascular tone + endothelial repair in aging cohorts.
1 supporting referencesVerified 13d ago
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Russian regulatory pathway only · grey-market in US/EU · no Western RCT body
Pre-filled with this compound's published dose range: 10 mg subcutaneous (Khavinson protocol) · daily × 10 days, 1-2× yearly
Draw volume exceeds 100 units (1 mL). Either reduce dose or split into multiple injections.
Calculator is a discussion tool. Verify reconstitution + dosing with a qualified provider. Stack is not a prescription source. Use sterile technique and inspect every vial.
No field reports yet
Field reports are added as users share their real-world protocols.
Next visit & citations
Handoff & sources
Running this compound? Log it in /history, then open Dr Passport before your visit. Methodology explains grades; the research dashboard sorts the full catalog with citations.